Literature DB >> 16103536

Preventing recurrent rheumatic fever: the role of register based programmes.

M McDonald, A Brown, S Noonan, J R Carapetis.   

Abstract

Despite dramatic gains of the last century, acute rheumatic fever and rheumatic heart disease remain major preventable causes of morbidity and mortality in many parts of the world.

Entities:  

Mesh：

Year:  2005        PMID： 16103536      PMCID： PMC1769085          DOI： 10.1136/hrt.2004.057570

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  10 in total

1.  Consent, confidentiality, and the threat to public health surveillance.

Authors:  Chris Verity; Angus Nicoll
Journal:  BMJ       Date:  2002-05-18

2.  WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-90). WHO Cardiovascular Diseases Unit and principal investigators.

Authors: 
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

3.  Evaluation and implementation of public health registries.

Authors:  D J Solomon; R C Henry; J G Hogan; G H Van Amburg; J Taylor
Journal:  Public Health Rep       Date:  1991 Mar-Apr       Impact factor: 2.792

Review 4.  Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: the decline of rheumatic fever.

Authors:  R W Quinn
Journal:  Rev Infect Dis       Date:  1989 Nov-Dec

5.  Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin.

Authors:  D G Tompkins; B Boxerbaum; J Liebman
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

6.  The community control of rheumatic fever and rheumatic heart disease: report of a WHO international cooperative project.

Authors:  T Strasser; N Dondog; A El Kholy; R Gharagozloo; V V Kalbian; O Ogunbi; S Padmavati; K Stuart; E Dowd; A Bekessy
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

7.  Current status of rheumatic fever control programs in the United States.

Authors:  E L Kaplan
Journal:  Public Health Rep       Date:  1981 May-Jun       Impact factor: 2.792

8.  A community-based rheumatic fever/rheumatic heart disease cohort: twelve-year experience.

Authors:  Rajesh Kumar; Anupam Raizada; Arun K Aggarwal; N K Ganguly
Journal:  Indian Heart J       Date:  2002 Jan-Feb

9.  Rheumatic fever in Minnesota. II. Evaluation of hospitalized patients and utilization of a State Rheumatic Fever Registry.

Authors:  M J Rice; E L Kaplan
Journal:  Am J Public Health       Date:  1979-08       Impact factor: 9.308

10.  Strategy for controlling rheumatic fever/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO/ISFC meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408
  10 in total
  20 in total

Review 1.  World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.

Authors:  Bo Reményi; Nigel Wilson; Andrew Steer; Beatriz Ferreira; Joseph Kado; Krishna Kumar; John Lawrenson; Graeme Maguire; Eloi Marijon; Mariana Mirabel; Ana Olga Mocumbi; Cleonice Mota; John Paar; Anita Saxena; Janet Scheel; John Stirling; Satupaitea Viali; Vijayalakshmi I Balekundri; Gavin Wheaton; Liesl Zühlke; Jonathan Carapetis
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

2.  Rheumatic heart disease in rural south India: A clinico-observational study.

Authors:  Manne Sriharibabu; Yalamanchali Himabindu; Zubair Kabir
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

Review 3.  Prevention and treatment of rheumatic heart disease in the developing world.

Authors:  Andrew C Steer; Jonathan R Carapetis
Journal:  Nat Rev Cardiol       Date:  2009-09-15       Impact factor: 32.419

4.  Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever.

Authors:  Christina F Pelajo; Jorge M Lopez-Benitez; Juliana M Torres; Sheila Kf de Oliveira
Journal:  Pediatr Rheumatol Online J       Date:  2010-07-26       Impact factor: 3.054

5.  Impact of regionalisation of a national rheumatic heart disease registry: the Ugandan experience.

Authors:  Emmy Okello; Chris T Longenecker; Amy Scheel; Twalib Aliku; Joselyn Rwebembera; Grace Mirembe; Craig Sable; Peter Lwabi; Andrea Beaton
Journal:  Heart Asia       Date:  2018-01-13

6.  Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.

Authors:  Anna P Ralph; Marea Fittock; Rosalie Schultz; Dale Thompson; Michelle Dowden; Tom Clemens; Matthew G Parnaby; Michele Clark; Malcolm I McDonald; Keith N Edwards; Jonathan R Carapetis; Ross S Bailie
Journal:  BMC Health Serv Res       Date:  2013-12-18       Impact factor: 2.655

7.  The case for global investment in rheumatic heart-disease control.

Authors:  Rosemary Wyber; Liesl Zühlke; Jonathan Carapetis
Journal:  Bull World Health Organ       Date:  2014-09-08       Impact factor: 9.408

8.  Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.

Authors:  Brunelle Gasse; Noémie Baroux; Bernard Rouchon; Jean-Michel Meunier; Isabelle De Frémicourt; Eric D'Ortenzio
Journal:  BMC Public Health       Date:  2013-02-12       Impact factor: 3.295

9.  Disparity in Mortality From Rheumatic Heart Disease in Indigenous Australians.

Authors:  Samantha M Colquhoun; John R Condon; Andrew C Steer; Shu Q Li; Steven Guthridge; Jonathan R Carapetis
Journal:  J Am Heart Assoc       Date:  2015-07-28       Impact factor: 5.501

10.  An open-access, mobile compatible, electronic patient register for rheumatic heart disease ('eRegister') based on the World Heart Federation's framework for patient registers.

Authors:  Joris van Dam; John Musuku; Liesl J Zühlke; Mark E Engel; Nick Nestle; Brigitta Tadmor; Jonathan Spector; Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2015-10-06       Impact factor: 1.167
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.